88
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Formation of ion pairing as an alternative to improve encapsulation and anticancer activity of all-trans retinoic acid loaded in solid lipid nanoparticles

, , , , , , & show all
Pages 6011-6020 | Published online: 12 Dec 2012

References

  • TangXHGudasLJRetinoids, retinoic acid receptors, and cancerAnnu Rev Pathol2011634536421073338
  • NilesRMSignaling pathways in retinoid chemoprevention and treatment of cancerMutat Res20045551–2819615476854
  • BushueNWanYJRetinoid pathway and cancer therapeuticsAdv Drug Deliv Rev201062131285129820654663
  • AdamsonPCPitotHCBalisFMRubinJMurphyRFPoplackDGVariability in the oral bioavailability of all-trans-retinoic acidJ Natl Cancer Inst199385129939968388479
  • MuindiJRFrankelSRHuseltonCClinical pharmacology of oral all-trans retinoic acid in patients with acute promyelocytic leukemiaCancer Res1992528213821421559217
  • AbdulmajedKHeardCMTopical delivery of retinyl ascorbate co-drug. 1. Synthesis, penetration into and permeation across human skinInt J Pharm20042801–211312415265552
  • ChungKDJeongYIChungCWKim doHKangDHAnti-tumor activity of all-trans retinoic acid-incorporated glycol chitosan nanoparticles against HuCC-T1 human cholangiocarcinoma cellsInt J Pharm20124221–245446122093956
  • LimSJLeeMKKimCKAltered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powdersJ Control Release20041001536115491810
  • ChansriNKawakamiSYamashitaFHashidaMInhibition of liver metastasis by all-trans retinoic acid incorporated into O/W emulsions in miceInt J Pharm20063211–2424916790329
  • KawakamiSSuzukiSYamashitaFHashidaMInduction of apoptosis in A549 human lung cancer cells by all-trans retinoic acid incorporated in DOTAP/cholesterol liposomesJ Control Release2006110351452116360957
  • MullerRHMaderKGohlaSSolid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the artEur J Pharm Biopharm200050116117710840199
  • JenningVLippacherAGohlaSHMedium scale production of solid lipid nanoparticles (SLN) by high pressure homogenizationJ Microencapsul200219111011811751
  • JoshiMDMullerRHLipid nanoparticles for parenteral delivery of activesEur J Pharm Biopharm200971216117218824097
  • JenningVGohlaSHEncapsulation of retinoids in solid lipid nanoparticles (SLN)J Microencapsul200118214915811253932
  • LimSJKimCKFormulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acidInt J Pharm20022431–213514612176302
  • HuLTangXCuiFSolid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugsJ Pharm Pharmacol200456121527153515563759
  • KayaliIWardAJSuheryTFribergSESimionARheinLDInteractions of retinoic acid with a model of stratum corneum lipidsJ Dermatol Clin Eval Soc19912717
  • CastroGAOreficeRLVilelaJMAndradeMSFerreiraLADevelopment of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acneJ Microencapsul200724539540717578730
  • CastroGACoelhoALOliveiraCAMahechaGAOreficeRLFerreiraLAFormation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticlesInt J Pharm20093811778319647057
  • Souza-FagundesEMQueirozABMartins FilhoOAScreening and fractionation of plant extracts with antiproliferative activity on human peripheral blood mononuclear cellsMem Inst Oswaldo Cruz20029781207121212563491
  • MosmannTRapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assaysJ Immunol Methods1983651–255636606682
  • RiccardiCNicolettiIAnalysis of apoptosis by propidium iodide staining and flow cytometryNat Protoc2006131458146117406435
  • MunsterUNakamuraCHaberlandARU 58841-myristate – prodrug development for topical treatment of acne and androgenetic alopeciaPharmazie200560181215700772
  • Schafer-KortingMMehnertWKortingHCLipid nanoparticles for improved topical application of drugs for skin diseasesAdv Drug Deliv Rev200759642744317544165
  • FanjulANBouterfaHDawsonMPfahlMPotential role for retinoic acid receptor-gamma in the inhibition of breast cancer cells by selective retinoids and interferonsCancer Res1996567157115778603404
  • HongTKLee-KimYCEffects of retinoic acid isomers on apoptosis and enzymatic antioxidant system in human breast cancer cellsNutr Res Pract200932778320016705
  • RobertsWRAddyMComparison of the in vivo and in vitro antibacterial properties of antiseptic mouthrinses containing chlorhexidine, alexidine, cetyl pyridinium chloride and hexetidine. Relevance to mode of actionJ Clin Periodontol1981842953106947993
  • LappalainenKJaaskelainenISyrjanenKUrttiASyrjanenSComparison of cell proliferation and toxicity assays using two cationic liposomesPharm Res1994118112711317971713
  • ScholerNOlbrichCTabattKMullerRHHahnHLiesenfeldOSurfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophagesInt J Pharm20012211–2576711397567
  • ZhuWYJonesCSKissAMatsukumaKAminSDe LucaLMRetinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cellsExp Cell Res199723422932999260897
  • MangiarottiRDanovaMAlbericiRPellicciariCAll-trans retinoic acid (ATRA)-induced apoptosis is preceded by G1 arrest in human MCF-7 breast cancer cellsBr J Cancer19987721861919460987
  • HwangSRLimSJParkJSKimCKPhospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administrationInt J Pharm20042761–217518315113624
  • SuJZhangNHoPCEvaluation of the pharmacokinetics of all-trans-retinoic acid (ATRA) in Wistar rats after intravenous administration of ATRA loaded into tributyrin submicron emulsion and its cellular activity on caco-2 and HepG2 cell linesJ Pharm Sci20089772844285317879972
  • ChenZXBreitmanTRTributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapyCancer Res19945413349434998012972
  • GiermaszANowisDJaliliAAntitumor activity of tributyrin in murine melanoma modelCancer Lett2001164214314811179828
  • LengsfeldCSPiteraDManningMRandolphTWDissolution and partitioning behavior of hydrophobic ion-paired compoundsPharm Res200219101572157612425478
  • MartinsSCosta-LimaSCarneiroTCordeiro-da-SilvaASoutoEBFerreiraDCSolid lipid nanoparticles as intracellular drug transporters: an investigation of the uptake mechanism and pathwayInt J Pharm20124301–221622722465548
  • SerpeLCatalanoMGCavalliRCytotoxicity of anticancer drugs incorporated in solid lipid nanoparticles on HT-29 colorectal cancer cell lineEur J Pharm Biopharm200458367368015451544
  • AltucciLLeibowitzMDOgilvieKMde LeraARGronemeyerHRAR and RXR modulation in cancer and metabolic diseaseNat Rev Drug Discov200761079381017906642
  • BonetMLRibotJPalouALipid metabolism in mammalian tissues and its control by retinoic acidBiochim Biophys Acta20121821117718921669299